PubRank

S Kuwahara

Author PubWeight™ 84.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother 1979 3.51
2 In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic. Antimicrob Agents Chemother 1984 3.35
3 In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother 2000 2.73
4 Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation. Antimicrob Agents Chemother 1980 2.59
5 Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration. J Antibiot (Tokyo) 1970 2.15
6 In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative. Antimicrob Agents Chemother (Bethesda) 1969 1.96
7 Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis. Antimicrob Agents Chemother 2000 1.93
8 Drug-sensitivity of El Tor vibrio strains isolated in the Philippines in 1964 and 1965. Bull World Health Organ 1967 1.67
9 Genetic behavior of R factors in Vibrio cholerae. J Bacteriol 1972 1.64
10 Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase. Antimicrob Agents Chemother 1979 1.61
11 Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics. J Antibiot (Tokyo) 1979 1.54
12 Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis. Antimicrob Agents Chemother 2000 1.48
13 Slime production by Pseudomonas aeruginosa. II. A new synthetic medium and cultural conditions suitable for slime production by Pseudomonas aeruginosa. Jpn J Microbiol 1973 1.45
14 Bicyclomycin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity. J Antibiot (Tokyo) 1972 1.42
15 In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic. J Antibiot (Tokyo) 1980 1.39
16 Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res 2000 1.32
17 [Transmission, by conjugation, of multiple drug-resistance from Shigella to Aeromonas and non-agglutinable Vibrio]. Nihon Saikingaku Zasshi 1966 1.17
18 Intrafamilial distribution of mutans streptococci in Japanese families and possibility of father-to-child transmission. Microbiol Immunol 1999 1.14
19 Cefazolin, a new semisynthetic cephalosporin antibiotic. IV. Antigenicity of cefazolin and its cross reactivity with benzylpenicillin, ampicillin and cephaloridine. J Antibiot (Tokyo) 1970 1.11
20 Adenosine 3',5'-cyclic monophosphate-deficient mutants of Vibrio cholerae. J Bacteriol 1974 1.06
21 Immunoactive peptides, FK-156 and FK-565. III. Enhancement of host defense mechanisms against infection. J Antibiot (Tokyo) 1983 1.06
22 Automatic and manual latex agglutination tests for measurement of cholera toxin and heat-labile enterotoxin of Escherichia coli. J Clin Microbiol 1983 1.04
23 In vitro antibacterial activity of FK482, a new orally active cephalosporin. J Antibiot (Tokyo) 1988 1.02
24 Pharmacokinetics of FK482, a new orally active cephalosporin, in animals. J Antibiot (Tokyo) 1988 0.99
25 Assay method for Vibrio cholerae and Escherichia coli enterotoxins by automated counting of floating chinese hamster ovary cells in culture medium. J Clin Microbiol 1978 0.97
26 Bactericidal activity of cefazolin, cefoxitin, and cefmetazole against Escherichia coli and Klebsiella pneumoniae. Chemotherapy 1982 0.96
27 In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem. Antimicrob Agents Chemother 1997 0.96
28 Inhibitory effect of Pseudomonas aeruginosa on the phagacytic and killing activities of rabbit polymorphonuclear leukocytes: purification and characterization of an inhibitor of polymorphonuclear leukocyte function. Infect Immun 1979 0.96
29 Inhibitory effect of Pseudomonas aeruginosa on the phagocytic and killing activity of rabbit polymorphonuclear leukocytes: mechanisms of action of a polymorphonuclear leukocyte inhibitor. Infect Immun 1979 0.95
30 Influence of parents' oral health behaviour on oral health status of their school children: an exploratory study employing a causal modelling technique. Int J Paediatr Dent 2002 0.95
31 Intensive glucose control after allogeneic hematopoietic stem cell transplantation: a retrospective matched-cohort study. Bone Marrow Transplant 2009 0.95
32 Increased adhesion of Chinese hamster ovary cells to substratum by cholera enterotoxin. Infect Immun 1975 0.94
33 Synergism of cephalosporins at subinhibitory concentrations and polymorphonuclear leukocytes on phagocytic killing of Escherichia coli and its mode of action. J Antibiot (Tokyo) 1986 0.91
34 Synthesis, structure-activity relationships, and pharmacokinetic profiles of nonpeptidic alpha-keto heterocycles as novel inhibitors of human chymase. J Med Chem 2001 0.90
35 Immunogenicity of cefazolin. Antimicrob Agents Chemother (Bethesda) 1970 0.89
36 Evidence for molecular identity of microsomal and mitochondrial NADH-cytochrome b5 reductases of rat liver. J Biochem 1978 0.89
37 Hydrolysis of S-2-aminoethylcysteinyl peptide bond by Achromobacter protease I. Biosci Biotechnol Biochem 1994 0.89
38 Bicyclomycin, a new antibiotic. IV. Absorption, excretion and tissue distribution. J Antibiot (Tokyo) 1972 0.88
39 Temperature-sensitive R plasmid obtained from naturally isolated drug-resistant Vibrio cholerae (biotype El Tor). Antimicrob Agents Chemother 1977 0.88
40 Transmission of the R factor by conjugation from a naturally-isolated, multiple drug-resistant strain of Vibrio eltor to Shigella and Salmonella. J Antibiot (Tokyo) 1969 0.88
41 Colistin disk--a differential method between Vibrio cholerae and Vibrio eltor. J Antibiot (Tokyo) 1966 0.88
42 In vivo antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin. J Antibiot (Tokyo) 1993 0.85
43 In vitro absorption and metabolism of nobiletin, a chemopreventive polymethoxyflavonoid in citrus fruits. Biosci Biotechnol Biochem 2001 0.85
44 Cephaloridine treatment of experimental rabbit syphilis. Postgrad Med J 1967 0.84
45 Efficacy of CS-834 against experimental pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae in mice. Antimicrob Agents Chemother 1998 0.84
46 Maridomycin, a new macrolide antibiotic. In vitro antibacterial activity of 9-propionylmaridomycin. Antimicrob Agents Chemother 1973 0.84
47 Local excision of benign rectal schwannoma using rectal expander-assisted transanal endoscopic microsurgery. Gastrointest Endosc 1998 0.84
48 Molecular dynamics in azobenzene liquid crystal polymer films measured by time-resolved techniques. Phys Chem Chem Phys 2014 0.83
49 Maridomycin, a new macrolide antibiotic: in vivo antibacterial activity of 9-propionylmaridomycin. Antimicrob Agents Chemother 1973 0.83
50 Immunochemical evidence for the participation of cytochrome b5 in the NADH synergism of the NADPH-dependent mono-oxidase system of hepatic microsomes. Biochem Biophys Res Commun 1974 0.82
51 Synergistic activity of ampicillin and cloxacillin. Protective effect of cloxacillin on enzymatic degradation of ampicillin by penicillinase, and therapeutic activity of mixtures of ampicillin and cloxacillin. J Antibiot (Tokyo) 1969 0.82
52 Effect of dipyridamole on zidovudine pharmacokinetics and short-term tolerance in asymptomatic human immunodeficiency virus-infected subjects. Antimicrob Agents Chemother 1994 0.82
53 Purification and characterization of four forms of cytochrome P-450 from liver microsomes of phenobarbital-treated and 3-methylcholanthrene-treated rats. J Biochem 1984 0.82
54 Evaluation of electrochemically generated ozone for the disinfection of water and wastewater. Water Sci Technol 2004 0.82
55 Studies on direct Coombs reaction by cefazolin in vitro. J Antibiot (Tokyo) 1970 0.81
56 The cycle of the seminiferous epithelium in the greater Japanese shrew mole, Urotrichus talpoides. J Vet Med Sci 2001 0.81
57 A novel (Pro79Thr) mutation in the FKHL7 gene in a Japanese family with Axenfeld-Rieger syndrome. Am J Ophthalmol 2001 0.81
58 Transduction of drug-resistances in Staphylococcus. II. Transduction of chloramphenicol-resistance in both Staphylococcus aureus and Staphylococcus epidermidis by typing phage 80. Jpn J Microbiol 1965 0.80
59 Medicinal alkaloid as a sex pheromone. Nature 1997 0.80
60 Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice. J Antibiot (Tokyo) 1983 0.79
61 Correction of scoliosis with shape-memory alloy. Nihon Seikeigeka Gakkai Zasshi 1993 0.79
62 Pyomelanin production by Pseudomonas aeruginosa. I. Transformation of pyomelanin productivity. Microbiol Immunol 1980 0.79
63 In vitro and in vivo evaluation of enduracidin, a new peptide antibiotic substance. J Antibiot (Tokyo) 1968 0.78
64 Determination of Pseudomonas aeruginosa by biochemical test methods. I. An improved method for gluconate oxidation test. Jpn J Microbiol 1970 0.78
65 Angiographic demonstration of growth of hepatocellular carcinoma in the hepatic vein and inferior vena cava. Radiology 1977 0.78
66 Different requirement for cytochrome b5 in NADPH-supported O-deethylation of p-nitrophenetole catalyzed by two types of microsomal cytochrome P-450. Biochem Biophys Res Commun 1980 0.78
67 Nature of monocyclic beta-lactam antibiotic Nocardicin A to beta-lactamases. Microbiol Immunol 1988 0.78
68 Antibiotic resistance of vibrio cholerae: special considerations of R-plasmids. Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi 1978 0.77
69 Animal pharmacokinetics of FK037, a novel parenteral broad-spectrum cephalosporin. J Antibiot (Tokyo) 1993 0.77
70 Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice. J Antibiot (Tokyo) 1983 0.77
71 Syntheses and evaluation of amidinobenzofuran derivatives as tryptase inhibitors. Bioorg Med Chem Lett 1999 0.76
72 Non-peptidic inhibitors of human chymase. Synthesis, structure-activity relationships, and pharmacokinetic profiles of a series of 5-amino-6-oxo-1,6-dihydropyrimidine-containing trifluoromethyl ketones. Bioorg Med Chem 2001 0.76
73 Synthesis, structure-activity relationships, and pharmacokinetic profiles of nonpeptidic difluoromethylene ketones as novel inhibitors of human chymase. J Med Chem 2001 0.76
74 Immunohistochemical study on blood-brain barrier in congenitally hydrocephalic HTX rat brain. Zentralbl Pathol 1994 0.76
75 Destruction of the platelet aggregating activity of ristocetin A. Experientia 1978 0.75
76 Inhibitory effect of Pseudomonas aeruginosa on phagocytosis and killing of rabbit polymorphonuclear leukocytes. Infect Immun 1980 0.75
77 Cyclic adenylic acid-dependent and -independent production of chloramphenicol acetyltransferase in Escherichia coli carrying R plasmids. Antimicrob Agents Chemother 1977 0.75
78 Degradation of host defenses against respiratory tract infection by Klebsiella pneumoniae in aged mice. Infect Immun 1988 0.75
79 [Recent development of beta-lactam drugs (author's transl)]. Nihon Saikingaku Zasshi 1979 0.75
80 Studies on direct Coombs reaction by cefazolin in vitro. Jpn J Antibiot 1970 0.75
81 Simple synthesis of 5,9-dimethylated long-chain alkanes, the sex pheromones of leaf miner moths. Biosci Biotechnol Biochem 2000 0.75
82 In vitro antibacterial activity of FK041, a new orally active cephalosporin. J Antibiot (Tokyo) 1999 0.75
83 [Toxicity of mercurials, especially methyl mercury compound, in chick embryo. II. Transfer of mercurials, which were administered to hens subcutaneously, into the eggs and toxicity of mercurials in chick-embryo]. Kumamoto Igakkai Zasshi 1970 0.75
84 Antigenicity of bicyclomycin and its cross-reactivity with benzylpenicillin. Jpn J Antibiot 1974 0.75
85 Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci. J Antibiot (Tokyo) 1993 0.75
86 Synthesis and topical antiinflammatory and antiallergic activities of antioxidant o-aminophenol derivatives. J Med Chem 1994 0.75
87 Mixed mesodermal tumor of the uterine cervix--a trial search for intermediate forms between carcinoma and sarcoma. Asia Oceania J Obstet Gynaecol 1985 0.75
88 [Reliability of sensitivity test value]. Saishin Igaku 1967 0.75
89 The influence of thapsigargin on Na,K-ATPase activity in cultured nonpigmented ciliary epithelial cells. Curr Eye Res 1995 0.75
90 Determination of Pseudomonas aeruginosa by biochemical test methods. II. Acylamidase test, a modified biochemical test for the identification of Pseudomonas aeruginosa. Jpn J Microbiol 1970 0.75
91 Effects of training in management of child behavior for dental hygiene students. ASDC J Dent Child 1998 0.75
92 [Changes of the chewing movements following the correction of anterior reversed occlusion in children]. Nihon Kyosei Shika Gakkai Zasshi 1989 0.75
93 In vivo antibacterial activity of FK041, a new orally active cephalosporin. J Antibiot (Tokyo) 1999 0.75
94 [Serum carcinoembryonic antigen (CEA) in liver diseases (author's transl)]. Nihon Shokakibyo Gakkai Zasshi 1979 0.75
95 [New anti-infective agents from the laboratory study of their introduction into the market]. Saishin Igaku 1968 0.75
96 In vitro and in vivo comparative evaluations of injectable cephalosporin derivatives and ampicillin. Chemotherapy 1976 0.75
97 [A clinical study of intracranial AVMs with reference to their enlargement and regression--a follow-up study with angiography and CT scan (author's transl)]. Neurol Med Chir (Tokyo) 1979 0.75
98 [A double blind comparative study of bacampicillin and talampicillin on scarlet fever (author's transl)]. Kansenshogaku Zasshi 1979 0.75
99 [Preparation of negamycin ointments. I. Possible utility of gel bases]. Yakugaku Zasshi 1986 0.75
100 [Pancreatic Function Diagnostant (PFD): a pancreatic exocrine function test with synthetic peptide, BT-PABA]. Nihon Rinsho 1980 0.75
101 In-vitro and in-vivo activities of a novel cephamycin MT-141 against the Bacteroides fragilis group in comparison with six cephem antibiotics. J Antimicrob Chemother 1985 0.75
102 Effect of N-3-(4-hydroxyphenyl)propionyl Pro-Pro-Gly-Ala-Gly on calcium-induced arrhythmias. Chem Pharm Bull (Tokyo) 1988 0.75
103 [Trypsin broth as a medium for cholera and El Tor vibrio. 1. Modification of the original formula]. Igaku To Seibutsugaku 1965 0.75
104 [Reproducibility of original and modified trypsin broths]. Igaku To Seibutsugaku 1966 0.75
105 [Preparation of negamycin ointments. II. Improvement in stability and antimicrobial activity]. Yakugaku Zasshi 1986 0.75
106 (R-Z)-7,15-hexadecadien-4-olide, sex pheromone of the yellowish elongate chafer, Heptophylla picea. Bioorg Med Chem 1996 0.75
107 Photoexcited carrier dynamics of double-layered CdS/CdSe quantum dot sensitized solar cells measured by heterodyne transient grating and transient absorption methods. Phys Chem Chem Phys 2014 0.75
108 Reduction in the local tissue toxicity of chlorpromazine by beta-cyclodextrin complexation. J Pharmacobiodyn 1983 0.75
109 [Drug choice based on the results of microbial sensitivity tests and its problems]. Naika 1967 0.75
110 [Ultracentrifugal analysis of lipoproteins]. Saishin Igaku 1972 0.75
111 Transmission of multiple drug-resistance from Shigella to Aeromonas and non-agglutinable Vibrio through conjugation. J Antibiot (Tokyo) 1967 0.75
112 [Effect of mercurials on the function of the brain. Especially the effect of methyl mercury compound on the activity of transaminase of aromatic amino acids in the brain of rats]. Kumamoto Igakkai Zasshi 1970 0.75
113 [Memorable items in my research]. Nihon Saikingaku Zasshi 1983 0.75
114 [Toxicity of mercurials, especially methyl mercury compound, in chick embryo. I. Toxicity of mercurials injected in fertilized chick egg]. Kumamoto Igakkai Zasshi 1970 0.75
115 [Studies on the combination of methyl mercury with the protein of egg white]. Nihon Eiseigaku Zasshi 1971 0.75
116 [The 20th Memorial Symposium at the Nursing Seminar of the Japan Red Cross for the professional staff. On the job training]. Kango Kyoiku 1972 0.75
117 [Test meal combined pancreatic functional diagnostant (PFD)--an attempt to improve diagnostic value of PFD (author's transl)]. Nihon Shokakibyo Gakkai Zasshi 1979 0.75
118 Evidence for a predominantly NADH-dependent O-dealkylating system in rat hepatic microsomes. Biochem Pharmacol 1985 0.75
119 [Recent advances in the isolation of Pseudomonas aeruginosa and related gram-negative rods]. Nihon Saikingaku Zasshi 1972 0.75
120 [Clinico-pathological study on the cervical involvement in rheumatoid arthritis]. Ryumachi 1983 0.75
121 Synthesis of southern (C1'-C11') and eastern (C8-C18) fragments of pamamycin-607, an aerial mycelium-inducing substance of Streptomyces alboniger. Biosci Biotechnol Biochem 2001 0.75
122 In vivo antibacterial activity of FK482, a new orally active cephalosporin. J Antibiot (Tokyo) 1988 0.75
123 [Prevalence of oral diseases in dental students]. Gifu Shika Gakkai Zasshi 1987 0.75
124 [Nursing records as a form of communication. A nursing record for a patient hospitalized for an extended period]. Kango Gijutsu 1986 0.75
125 Effect of acetylcholine on the membrane conductance of the intralobular duct cells of the rat exorbital lacrimal gland. Adv Exp Med Biol 1994 0.75
126 Platelet anti-aggregant activity of 2,2-dimethylthiazolidine hydrochloride and 2-(4-hydroxy-3-methoxyphenyl)thiazolidine. Chem Pharm Bull (Tokyo) 1988 0.75
127 Novel method of screening the oxidation and reduction abilities of photocatalytic materials. Analyst 2014 0.75
128 Relationship between gingival health and dental caries in children aged 7-12 years. J Oral Sci 2000 0.75
129 [Differentiation of cholera Vibrio from El Tor vibrios by a trypsin broth medium. II. Heat-sterilized trypsin broth]. Igaku To Seibutsugaku 1965 0.75
130 [Transfer of mercury in hens to which phenylmercury acetate was administered subcutaneously, to eggs and toxicity of mercury on chick-embryo]. Nihon Eiseigaku Zasshi 1970 0.75
131 [3 cases of giant bursal cyst due to rheumatoid arthritis ]. Ryumachi 1982 0.75
132 [A case of acute pancreatitis with hyperlipemia during pregnancy (author's transl)]. Nihon Shokakibyo Gakkai Zasshi 1979 0.75
133 [Genetic characteristics of R factor of Vibrio cholerae and adaptive development of resistance]. Nihon Saikingaku Zasshi 1975 0.75
134 Role of the cephalosporinase gene in the resistance of the clinically isolated cephem-resistant Escherichia coli. J Antibiot (Tokyo) 1988 0.75
135 [Exfoliative cytology of mixed mesodermal tumors of the uterus--review of cytologic smears sampled prior to therapy]. Nihon Sanka Fujinka Gakkai Zasshi 1985 0.75
136 [Computed tomography in the evaluation of hepatic hemangioma (author's transl)]. Rinsho Hoshasen 1981 0.75
137 [On the nuisance of odors in Yatsushiro, Kumamoto prefecture, Japan. II. Distributions of hydrogen sulphide in the atmospheric air of Yatsushiro]. Kumamoto Igakkai Zasshi 1968 0.75
138 The effect of increasing gastric pH upon the bioavailability of orally-administered foscarnet. Antiviral Res 1998 0.75
139 [Studies on the origin of the causative agent of Minamata disease. IX. Transition of the pollution of Minamata Bay and its neighbourhood]. Nihon Eiseigaku Zasshi 1967 0.75
140 [Effect of mercurials administered to roosters on the rate of hatching from eggs of hens mated with roosters]. Nihon Eiseigaku Zasshi 1970 0.75